Real World Evidence

Market Access

Pharma go-to-market transformation: Why cross-functional sil...

Pharmaceutical go-to-market transformation has become the industry's most urgent priority, yet cross-functional coordination remains pharma's biggest challenge.

R&D

Transforming drug development with statistical methodologies

The product development lifecycle is long and challenging.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Market Access

Bridging research and clinical guidelines – interactive stra...

Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

R&D

The future of patient registries: Leveraging technology for ...

The healthcare industry has a growing need for real world evidence (RWE) and the capture of holistic longitudinal outcomes.

News

A pair of spectacles in front of computer screens

Does Roche have buyer's remorse for Flatiron takeover?

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion.

News

Aptar buys digital health partner Healint

More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well